| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80952a626927f973fd89c14ca28c0ed2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd2c7d9b6d5f87afe5aaaf166df2690
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_866dd94f2bf4c2214e0eca5743b51413 |
| publicationDate |
2020-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200080331-A |
| titleOfInvention |
Glucagon analogues |
| abstract |
The present invention relates to glucagon analogs and their medical use, for example in the treatment of hypoglycemia. In particular, the present invention relates to stable glucagon analogs suitable for use in liquid formulations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022129312-A1 |
| priorityDate |
2012-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |